Each retrieved citation was reviewed by two independently working reviewers (A.R. and J.D.). Most articles were excluded on the basis of information provided by the title or abstract. Citations that appeared to be appropriate or those that could not be excluded unequivocally from the title and abstract were identified, and the corresponding full text reports were reviewed by the two reviewers. Any disagreement between them was resolved by reviewer consensus. From the included articles, the following data were extracted: patient demographics, diagnoses, type of surgery, details of vertebral artery (VA) injury and treatment, and risk factors for VA injury.
Study Quality
Articles selected for inclusion were classified by level of evidence. The method used for assessing the quality of evidence of individual studies as well as the overall quality of the body of evidence incorporates aspects of the rating scheme developed by the Oxford Centre for Evidence-Based precepts outlined by the Grades of Recommendation Assessment, Development and Evaluation Working Group, 3 and recommendations made by the Agency for Healthcare Research and Quality (AHRQ). 4 Each individual study was rated by two different investigators against preset criteria that resulted in an evidence rating (level of evidence I, II, III, or IV). Disagreements were resolved through discussion.
Determination of Overall Strength of Evidence
After individual article evaluation, the overall body of evidence with respect to each outcome is determined based on precepts outlined by the Grades of Recommendation Assessment, Development and Evaluation Working Group 3 and recommendations made by the Agency for Healthcare Research and Quality (AHRQ). 4 Qualitative analysis is performed considering the following AHRQ required and additional domains. 5 ►Table 6 provides an outline of the method used to determine the final strength of evidence (SoE). 
Patients at similar point in the course of their disease or treatment
Patients followed long enough for outcomes to occur IV  IV  III  III  IV  IV  II  IV  III  IV  IV  IV Note: Blank cell indicates criterion not met, could not be determined, or information not reported by the author.
Controlling for extraneous prognostic factors

Evidence level
Evidence-Based Spine-Care Journal Vol. 5 No. 1/2014
• Risk of bias is evaluated during the individual study evaluation described above. After individual article review, the literature evidence was rated as "high" initially if the majority of the articles are level I or II. It is rated as "low" if the majority were level III or lower. This is the "baseline" SoE, online supplementary "4a. Critical appraisal for studies reporting incidence rate and treatment outcomes of VA injuries." The consistency, directness, precision, and subgroup effects are considered for potential "downgrading" the strength of the body of evidence (one or two levels depending on the degree and number of domain violations).
Criteria Evaluated for "Downgrading"
• Consistency refers to the degree of similarity in the effect sizes of different studies within an evidence base. If effect sizes indicate the same direction of effect and if the range of effect sizes is narrow, an evidence base was judged to be consistent. If meta-analyses were conducted, we evaluated the consistency with an "eye ball test." This test consists of a visual appraisal of the forest plots by two independent reviewers. Single study evidence bases were judged "consistency unknown (single study)" and downgraded.
• Directness is concerned with whether the evidence being assessed reflected a single, direct link between the A good case-control study must have all of the following: all incident cases from the defined population over a specified time period, controls that represent the population from which the cases come, exposure that precedes an outcome of interest, and accounting for other prognostic factors. e A good cross-sectional study must have all of the following: a representative sample of the population of interest, an exposure that precedes an outcome of interest (e.g., sex, genetic factor), an accounting for other prognostic factors, and for surveys, at least an 80% return rate. f A case series design for prognosis is one where all the patients in the study have the exposure of interest. Since all the patients have the exposure, risks of an outcome can be calculated only for those with the exposure, but cannot be compared with those who do not have the exposure. For example, a case series evaluating the effect of smoking on spine fusion that only recruits patients who smoke can simply provide the risk of patients who smoke that result in pseudarthrosis but cannot compare this risk to those that do not smoke.
Evidence-Based Spine-Care Journal Vol. interventions of interest and the ultimate health outcome; that is, a determination of whether the most clinically relevant outcome was measured or if a surrogate outcome was assessed. Directness also applies to indirect comparisons of treatment when head to head comparisons of interest could not made within individual studies.
• Precision of evidence pertains to the degree of certainty surrounding an estimate of effect for a specific outcome. This is based on whether the estimate of effect reached statistical significance and/or the inspection of confidence intervals around effect estimates. When there are only two subgroups, the overlap of the confidence intervals of the summary estimates of the two groups is considered. No overlap of the confidence intervals indicates statistical significance, but the confidence intervals can overlap to a small degree and the difference still is statistically significant.
• Subgroup effects: For evaluating subgroup effects (i.e., heterogeneity of treatment effects), we downgrade if the authors do not state a priori their plan to perform subgroup analyses and if there was no test for interaction. Criteria Used for "Upgrading"
• Finally, if the SoE is less than "high," we "upgrade" the evidence if there is a dose-response association or a strong magnitude of effect.
The following four possible levels and their definition are reported:
• High: High confidence that the evidence reflects the true effect. Further research is very unlikely to change our confidence in the estimate of effect.
• Moderate: Moderate confidence that the evidence reflects the true effect. Further research may change our confidence in the estimate of effect and may change the estimate.
• Low: Low confidence that the evidence reflects the true effect. Further research is likely to change the confidence in the estimate of effect and likely to change the estimate.
• Insufficient: Evidence either is unavailable or does not permit a conclusion. 
